Skip to content
    U

    UPMC

    UPMC is a Series A to Series B stage investment firm. It has made 10 investments. 59% of their portfolio is in Healthcare. Average disclosed round size is $19.7M (across 17 rounds with reported amounts).

    Find people at UPMC on Goldilocks AI

    Portfolio

    10

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    FY

    Fiona Yung

    Sr. Director, Investments

    MK

    Matthias Kleinz

    Life Science Investor and Executive Vice President

    Portfolio Breakdown

    Stage Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    17 investments
    CompanyRoundAmountDate
    OOptain HealthSeries A$26MSep 2025
    Xealth logoXealthIpo$50MJan 2025
    Xealth logoXealthIpo$50MJan 2025
    Medicom logoMedicomSeries B$21.8MNov 2021
    Xealth logoXealthSeries B$24MSep 2021
    Xealth logoXealthSeries B$24MSep 2021
    GGlobin SolutionsUnknown$1.8MMar 2020
    Xealth logoXealthSeries A$11MMar 2019
    Xealth logoXealthSeries A$11MMar 2019
    Xealth logoXealthSeries A$11MJan 2019
    GGlobin SolutionsSeries A$5MMay 2018
    Xealth logoXealthUnknown$8.5MJan 2017
    KKoda HealthSeries A$7M—
    AAvista TherapeuticsSeed$10M—
    MMedCPUUnknown$35M—
    Vivify Health logoVivify HealthUnknown$3M—
    Alung Technologies logoAlung TechnologiesSeries C$36M—

    Top Co-Investors

    Last updated: 20 October 2026